Starpharma Holdings Limited (SPL)

 NULL
   
  • 52 Week High: NULL
  • 52 Week Low: $0.09
  • Currency: Australian Dollars
  • Shares Issued: 371.69m

SPL Overview

Starpharma Holdings Limited develops dendrimer nanotechnology products for pharmaceutical, life-science and other applications. Its lead product is VivaGel, a gel-based vaginal microbicide to protect women from the sexually transmitted infections, HIV and genital herpes.

Listings

Index: ASX All Ordinaries
ISIN: AU000000SPL0

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are end of day values only.

 

SPL Market Data

Currency Australian Dollars
% Change 0.00 %
52 Week High NULL
52 Week Low $0.09
Shares Issued 371.69m

Top of Page